FRI106 Outcomes Of SGLT2 Inhibitors In Patients With Heart Failure With Or Without Diabetes In A Tertiary Care Center In Saudi Arabia

Disclosure: S.F. Alqifari: None. A. Mohammed: None. E. Anwar: None. K. Niazi: None. R. Aldawish: None. M. Mutlaq: None. M. Binsaqr: None. A. Khojah: None. R. Albahli: None. P. Amirthalingam: None. A. Aljabri: None. S. Ziada: None. B. Alshaye: None. S. Almlkhlef: None. Objectives: The role of Sodium-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqifari, Saleh F, Mohammed, Adil, Anwar, Eman, Niazi, Kashan, Aldawish, Rahaf, Mutlaq, Mai, Binsaqr, Maha, Khojah, Asmaa, Albahli, Rand, Amirthalingam, Palanisamy, Aljabri, Ahmed, Ziada, Shimaa, Alshaye, Bshaier, Almlkhlef, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553511/
http://dx.doi.org/10.1210/jendso/bvad114.619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553511/
http://dx.doi.org/10.1210/jendso/bvad114.619

Ejemplares similares